116 related articles for article (PubMed ID: 16904644)
1. SUMO down-regulates the activity of Elf4/myeloid Elf-1-like factor.
Suico MA; Nakamura H; Lu Z; Saitoh H; Shuto T; Nakao M; Kai H
Biochem Biophys Res Commun; 2006 Sep; 348(3):880-8. PubMed ID: 16904644
[TBL] [Abstract][Full Text] [Related]
2. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx.
Kuo HY; Chang CC; Jeng JC; Hu HM; Lin DY; Maul GG; Kwok RP; Shih HM
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):16973-8. PubMed ID: 16287980
[TBL] [Abstract][Full Text] [Related]
3. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
[TBL] [Abstract][Full Text] [Related]
4. Sp1-dependent regulation of Myeloid Elf-1 like factor in human epithelial cells.
Koga T; Suico MA; Nakamura H; Taura M; Lu Z; Shuto T; Okiyoneda T; Kai H
FEBS Lett; 2005 May; 579(13):2811-6. PubMed ID: 15907486
[TBL] [Abstract][Full Text] [Related]
5. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome.
Seki Y; Suico MA; Uto A; Hisatsune A; Shuto T; Isohama Y; Kai H
Cancer Res; 2002 Nov; 62(22):6579-86. PubMed ID: 12438253
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity.
Brunet Simioni M; De Thonel A; Hammann A; Joly AL; Bossis G; Fourmaux E; Bouchot A; Landry J; Piechaczyk M; Garrido C
Oncogene; 2009 Sep; 28(37):3332-44. PubMed ID: 19597476
[TBL] [Abstract][Full Text] [Related]
7. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties.
Miyazaki Y; Sun X; Uchida H; Zhang J; Nimer S
Oncogene; 1996 Oct; 13(8):1721-9. PubMed ID: 8895518
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity.
Berta MA; Mazure N; Hattab M; Pouysségur J; Brahimi-Horn MC
Biochem Biophys Res Commun; 2007 Aug; 360(3):646-52. PubMed ID: 17610843
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation differentially regulates Goosecoid-mediated transcriptional repression.
Izzi L; Narimatsu M; Attisano L
Exp Cell Res; 2008 Apr; 314(7):1585-94. PubMed ID: 18336814
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of DNA binding of Sox2 by the SUMO conjugation.
Tsuruzoe S; Ishihara K; Uchimura Y; Watanabe S; Sekita Y; Aoto T; Saitoh H; Yuasa Y; Niwa H; Kawasuji M; Baba H; Nakao M
Biochem Biophys Res Commun; 2006 Dec; 351(4):920-6. PubMed ID: 17097055
[TBL] [Abstract][Full Text] [Related]
11. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
[TBL] [Abstract][Full Text] [Related]
12. MEF up-regulates human beta-defensin 2 expression in epithelial cells.
Lu Z; Kim KA; Suico MA; Shuto T; Li JD; Kai H
FEBS Lett; 2004 Mar; 561(1-3):117-21. PubMed ID: 15013761
[TBL] [Abstract][Full Text] [Related]
13. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
[TBL] [Abstract][Full Text] [Related]
14. Sp1 is involved in the transcriptional activation of lysozyme in epithelial cells.
Suico MA; Koga T; Shuto T; Hisatsune A; Lu Z; Basbaum C; Okiyoneda T; Kai H
Biochem Biophys Res Commun; 2004 Nov; 324(4):1302-8. PubMed ID: 15504356
[TBL] [Abstract][Full Text] [Related]
15. Liver receptor homolog-1 localization in the nuclear body is regulated by sumoylation and cAMP signaling in rat granulosa cells.
Yang FM; Pan CT; Tsai HM; Chiu TW; Wu ML; Hu MC
FEBS J; 2009 Jan; 276(2):425-36. PubMed ID: 19125815
[TBL] [Abstract][Full Text] [Related]
16. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells.
Pan MR; Chang TM; Chang HC; Su JL; Wang HW; Hung WC
J Cell Sci; 2009 Sep; 122(Pt 18):3358-64. PubMed ID: 19706680
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the dual-function transcription factor Sp3 by SUMO.
Valin A; Gill G
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1393-6. PubMed ID: 18031229
[TBL] [Abstract][Full Text] [Related]
18. SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1.
Salinas S; Briançon-Marjollet A; Bossis G; Lopez MA; Piechaczyk M; Jariel-Encontre I; Debant A; Hipskind RA
J Cell Biol; 2004 Jun; 165(6):767-73. PubMed ID: 15210726
[TBL] [Abstract][Full Text] [Related]
19. SUMO modification of Sam68 enhances its ability to repress cyclin D1 expression and inhibits its ability to induce apoptosis.
Babic I; Cherry E; Fujita DJ
Oncogene; 2006 Aug; 25(36):4955-64. PubMed ID: 16568089
[TBL] [Abstract][Full Text] [Related]
20. Something about SUMO inhibits transcription.
Gill G
Curr Opin Genet Dev; 2005 Oct; 15(5):536-41. PubMed ID: 16095902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
